A transdermalis hormonpótló kezelés alkalmazhatósága a postmenopausalis panaszokban szenvedö betegek fokozott rizikójú csoportjában.

Research output: Article

2 Citations (Scopus)

Abstract

The authors studied whether hormone replacement therapy can be performed in postmenopausal patients with high risk factors among anamnestic data such as thromboembolia, diabetes mellitus, hypertension, epilepsy. 50 mg 17 beta estradiol patch (twice weekly) and 10 mg medroxyprogesteron (in the last 12 days of the cycle) were prescribed. Data of 102 patients with the above conditions were analyzed at the beginning and at the 3,6, and 12 month follow-up visits. The frequency of exacerbation of anamnestic disease, biased and unbiased complaints, efficacy and side effects of the therapy were studied. In the authors opinion hormone replacement therapy can be safely performed in patients with high risk factors among anamnestic data, in addition it may be useful to prevent them.

Original languageHungarian
Pages (from-to)2025-2028
Number of pages4
JournalOrvosi Hetilap
Volume137
Issue number37
Publication statusPublished - szept. 15 1996

Fingerprint

Hormone Replacement Therapy
Hormones
Medroxyprogesterone
Disease Progression
Estradiol
Epilepsy
Diabetes Mellitus
Hypertension
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{2691a05aa22243faadeaf9be0f5a8f3d,
title = "A transdermalis hormonp{\'o}tl{\'o} kezel{\'e}s alkalmazhat{\'o}s{\'a}ga a postmenopausalis panaszokban szenved{\"o} betegek fokozott rizik{\'o}j{\'u} csoportj{\'a}ban.",
abstract = "The authors studied whether hormone replacement therapy can be performed in postmenopausal patients with high risk factors among anamnestic data such as thromboembolia, diabetes mellitus, hypertension, epilepsy. 50 mg 17 beta estradiol patch (twice weekly) and 10 mg medroxyprogesteron (in the last 12 days of the cycle) were prescribed. Data of 102 patients with the above conditions were analyzed at the beginning and at the 3,6, and 12 month follow-up visits. The frequency of exacerbation of anamnestic disease, biased and unbiased complaints, efficacy and side effects of the therapy were studied. In the authors opinion hormone replacement therapy can be safely performed in patients with high risk factors among anamnestic data, in addition it may be useful to prevent them.",
author = "F. Szalay and C. Horv{\'a}th",
year = "1996",
month = "9",
day = "15",
language = "Hungarian",
volume = "137",
pages = "2025--2028",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "37",

}

TY - JOUR

T1 - A transdermalis hormonpótló kezelés alkalmazhatósága a postmenopausalis panaszokban szenvedö betegek fokozott rizikójú csoportjában.

AU - Szalay, F.

AU - Horváth, C.

PY - 1996/9/15

Y1 - 1996/9/15

N2 - The authors studied whether hormone replacement therapy can be performed in postmenopausal patients with high risk factors among anamnestic data such as thromboembolia, diabetes mellitus, hypertension, epilepsy. 50 mg 17 beta estradiol patch (twice weekly) and 10 mg medroxyprogesteron (in the last 12 days of the cycle) were prescribed. Data of 102 patients with the above conditions were analyzed at the beginning and at the 3,6, and 12 month follow-up visits. The frequency of exacerbation of anamnestic disease, biased and unbiased complaints, efficacy and side effects of the therapy were studied. In the authors opinion hormone replacement therapy can be safely performed in patients with high risk factors among anamnestic data, in addition it may be useful to prevent them.

AB - The authors studied whether hormone replacement therapy can be performed in postmenopausal patients with high risk factors among anamnestic data such as thromboembolia, diabetes mellitus, hypertension, epilepsy. 50 mg 17 beta estradiol patch (twice weekly) and 10 mg medroxyprogesteron (in the last 12 days of the cycle) were prescribed. Data of 102 patients with the above conditions were analyzed at the beginning and at the 3,6, and 12 month follow-up visits. The frequency of exacerbation of anamnestic disease, biased and unbiased complaints, efficacy and side effects of the therapy were studied. In the authors opinion hormone replacement therapy can be safely performed in patients with high risk factors among anamnestic data, in addition it may be useful to prevent them.

UR - http://www.scopus.com/inward/record.url?scp=0030587106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030587106&partnerID=8YFLogxK

M3 - Article

C2 - 8927357

AN - SCOPUS:0030587106

VL - 137

SP - 2025

EP - 2028

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 37

ER -